Extend Biosciences is an emerging biotechnology company developing a novel drug delivery platform technology.
Extend Biosciences has raised $200K in total funding. The most recent round was Grant. The last funding was announced in June 2022.
Extend Biosciences's investors include National Science Foundation, MassChallenge, MassVentures.
Extend Biosciences is headquartered in Cambridge, United States.
Extend Biosciences is an emerging biotechnology company developing a novel drug delivery platform technology.
Extend Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Extend Biosciences — Funding & Investors." VCBacked, June 30, 2022, https://www.vcbacked.co/company/extend-biosciences. Accessed July 20, 2026.
VCBacked. (2022). Extend Biosciences — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/extend-biosciences
{{cite web |title=Extend Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/extend-biosciences |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated